Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Tox21_300558

    Client Email Product

    Tox21_300558

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    21
    US DMFs Filed

    US DMFs Filed

    15
    CEP/COS Certifications

    CEP/COS Certifications

    2
    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    8
    Other Suppliers

    Other Suppliers

    10
    API REF. PRICE (USD / KG)
    736

    API Market Place

    16
    INTERMEDIATES
    2
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    30
    Europe

    Europe

    1
    Canada

    Canada

    4
    Australia

    Australia

    4
    South Africa

    South Africa

    1
    Uploaded Dossiers

    Uploaded Dossiers

    5
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    71.00

    Annual Reports

    56.00

    FDF Market Place

    4
    EXCIPIENTS
    94
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    3

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    24
    REF STANDARD

    EDQM

    1

    USP

    1

    JP

    0

    Other Listed Suppliers

    1
    SERVICES

    0

    left grey arrow
    right gray arrow
    • GEL;TOPICAL - 7.5%
    • TABLET;ORAL - 25MG
    • TABLET;ORAL - 100MG
    Full View ScreenFull Screen View
    Padagis' Generic Teriparatide Receives Approval in the U.S.
    Padagis' Generic Teriparatide Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212657

    FDA
    01 Nov 2023
    Share Share
    Encube's Generic Dapsone Receives Approval in the U.S.
    Encube's Generic Dapsone Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212383

    FDA
    13 Oct 2023
    Share Share
    Acrux's Generic Dapsone Receives Approval in the U.S.
    Acrux's Generic Dapsone Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213907

    FDA
    06 Jun 2023
    Share Share
    Torrent's Generic Dapsone Receives Approval in the U.S.
    Torrent's Generic Dapsone Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214722

    FDA
    10 Feb 2022
    Share Share
    Mylan's Generic Dapsone Receives Approval in the U.S.
    Mylan's Generic Dapsone Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213847

    FDA
    04 Feb 2022
    Share Share
    Torrent Pharms Generic Dapsone Receives Approval in US
    Torrent Pharms Generic Dapsone Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214722

    FDA
    20 Oct 2021
    Share Share
    Torrent's Generic Dapsone Receives Approval In US
    Torrent's Generic Dapsone Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214722

    FDA
    15 Oct 2021
    Share Share
    Taro Pharms' Generic Dapsone Receives Approval In US
    Taro Pharms' Generic Dapsone Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210191

    FDA
    26 Jun 2019
    Share Share
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics

    https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic

    Angus Liu FIERCE PHARMA
    21 Jun 2019
    Share Share
    Sai Life Sciences Generic Dapsone Receives Approval in US
    Sai Life Sciences Generic Dapsone Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207165

    FDA
    13 May 2019
    Share Share
    Taro Pharm`s Generic Dapsone Receives Approval in US
    Taro Pharm`s Generic Dapsone Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209430

    FDA
    05 Mar 2019
    Share Share
    Taro Pharma USA's Generic Dapsone Receives Tentative Approval in US
    Taro Pharma USA's Generic Dapsone Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210191

    FDA
    12 Dec 2018
    Share Share
    Almirall acquires Allergan U.S. medical dermatology portfolio
    Almirall acquires Allergan U.S. medical dermatology portfolio

    https://www.prnewswire.com/news-releases/almirall-acquires-allergan-us-medical-dermatology-portfolio-300716808.html

    PR NEWSWIRE
    21 Sep 2018
    Share Share
    Almirall acquires Allergan's US dermatology portfolio for $650 million
    Almirall acquires Allergan's US dermatology portfolio for $650 million

    http://www.pharmatimes.com/news/almirall_acquires_allergans_us_dermatology_portfolio_for_$650_million_1246917

    G Underwood PHARMA TIMES
    03 Aug 2018
    Share Share
    Taro’s Generic Dapsone Receives Approval In US
    Taro’s Generic Dapsone Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209506

    FDA
    18 Oct 2017
    Share Share
    New or extended uses, or new combinations of registered medicines
    New or extended uses, or new combinations of registered medicines

    https://www.tga.gov.au/prescription-medicines-new-or-extended-uses-registered-medicines

    TGA
    05 Jul 2017
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Dapsone Gel & Epinephrine Injection
    FDA Confirms Paragraph IV Patent Challenge of Dapsone Gel & Epinephrine Injection

    https://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/abbreviatednewdrugapplicationandagenerics/ucm047676.htm

    FDA
    25 Apr 2017
    Share Share
    Sienna Biopharmaceuticals Acquires Creabilis plc
    Sienna Biopharmaceuticals Acquires Creabilis plc

    http://www.prnewswire.com/news-releases/sienna-biopharmaceuticals-acquires-creabilis-plc-300373769.html

    PR NEWSWIRE
    06 Dec 2016
    Share Share
    Par's Generic Dapsone Receives Approval In US
    Par's Generic Dapsone Receives Approval In US

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206505

    FDA
    01 Dec 2016
    Share Share
    Kate Bosworth Partners with Allergan to Celebrate Launch of ACZONE
    Kate Bosworth Partners with Allergan to Celebrate Launch of ACZONE

    http://www.prnewswire.com/news-releases/kate-bosworth-partners-with-allergan-to-celebrate-launch-of-aczone-dapsone-gel-75-in-new-york-city-300279936.html

    PR NEWSWIRE
    06 Jun 2016
    Share Share
    North Creek Pharm's Generic Dapsone approved in US for Dermatitis herpetiformis
    North Creek Pharm's Generic Dapsone approved in US for Dermatitis herpetiformis

    https://www.pharmacompass.com/pdf/news/north-creek-pharms-generic-dapsone-approved-in-us-for-dermatitis-herpetiformis-1463220049.pdf

    FDA
    10 May 2016
    Share Share
    Nostrum Lab's Generic Dapsone approved in US for Dermatitis herpetiformis
    Nostrum Lab's Generic Dapsone approved in US for Dermatitis herpetiformis

    https://www.pharmacompass.com/pdf/news/nostrum-labs-generic-dapsone-approved-in-us-for-dermatitis-herpetiformis-1463138352.pdf

    FDA
    06 May 2016
    Share Share
    Allergan's Aczone(Dapsone) approved in US to treat acne
    Allergan's Aczone(Dapsone) approved in US to treat acne

    https://www.pharmacompass.com/pdf/news/allergans-aczonedapsone-approved-in-us-to-treat-acne-1456488183.pdf

    FDA
    24 Feb 2016
    Share Share
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

    Eric Palmer FIERCE PHARMA MFG
    02 May 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Nuray Dapsone

    Access Virtual Booth

    Contact Supplier

    View Presentation

    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search